TICKERNERD
Menu
AMTXAMTXBasic Materials · Specialty Chemicals

AMTX Stock Forecast: Aemetis, Inc. Price Predictions for 2026-2027

Last close, 3 Aug 2026
$1.52
+0.66% on the day

The 4 Wall Street analysts covering Aemetis, Inc. hold a median 12-month price target of $13 — +722.4% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 29 of 100 as at 1 Aug 2026 — in the lower half. The Street sees upside; the factor read is a caution. That gap is the story on this page.

Market cap
$106.3M
Ticker Nerd rank
29 / 100
Median analyst target
$13
Analysts covering
4
Total return, dividends reinvested
1W
−2.3%
1M
−7.9%
YTD
+9.4%
1Y
−43.9%
From 52W high
−58.5%
From 52W low
+15.2%
$1.32
$3.66
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

AMTX stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores Aemetis, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 1 Aug 2026
29 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Growth
81
Size
74
Accruals
61
Revisions
41
Quality
38
Volatility
31
Value
28
Momentum
25
Issuance
7

Growth (81): Sales and profits are climbing, and climbing faster than before.

Issuance (7): The company has been issuing shares or taking on financing, diluting existing holders.

The rank is the raw material. Whether the rules would actually own Aemetis, Inc. — and when they’d sell — is the membership.

Wall Street

AMTX stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on AMTX, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$−5.00$0.00$5.00$10.00$15.00$20.00$25.00$30.00Oct 25Jan 26Apr 26Jul 26AMTXHigh $28Median $13Low $3

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

What Wall Street says4 analysts
3 Buy1 Hold0 Sell
Low $3Median $13High $28

The green dot is the last close — the median target sits +722.4% from it.

Recent analyst actionsNewest first
DateFirmActionRatingTarget
22 May 2026Ascendiant CapitalMaintainsBuy$21 → $22
8 Apr 2026Ascendiant CapitalMaintainsBuy—
19 Nov 2025Ascendiant CapitalMaintainsBuy—
6 Oct 2025Ascendiant CapitalMaintainsBuy—
30 June 2025UBSMaintainsBuy—
6 June 2025Ascendiant CapitalMaintainsBuy—
9 May 2025UBSMaintainsBuy—
17 Mar 2025Ascendiant CapitalMaintainsBuy—
14 Mar 2025HC Wainwright & Co.ReiteratesBuy—
23 Dec 2024HC Wainwright & Co.ReiteratesBuy—
15 Nov 2024HC Wainwright & Co.ReiteratesBuy—
3 Sept 2024Ascendiant CapitalMaintainsBuy—
19 Aug 2024UBSMaintainsBuy—
2 Aug 2024HC Wainwright & Co.ReiteratesBuy—
31 July 2024Truist SecuritiesReiteratesHold—
13 May 2024Truist SecuritiesReiteratesHold—
10 May 2024HC Wainwright & Co.ReiteratesBuy—
8 Mar 2024HC Wainwright & Co.ReiteratesBuy—
21 Feb 2024StifelMaintainsBuy—
23 Jan 2024StifelMaintainsBuy—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Estimates

AMTX analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
Analysts raising
0
Analysts cutting
1
Fundamentals

Aemetis, Inc. (AMTX) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
−1.2×

Cheaper than 82% of US stocks

Price / sales
0.5×

Cheaper than 83% of US stocks

Price / book
−0.3×

Cheaper than 93% of US stocks

EV / EBITDA
−35.2×

Cheaper than 92% of US stocks

Growth & margins
Revenue growth (YoY)
27.4%

Higher than 78% of US stocks

Earnings growth (YoY)
27.4%

Higher than 67% of US stocks

Gross margin
5.0%

Higher than 7% of US stocks

Operating margin
−11.6%

Higher than 25% of US stocks

Net margin
−33.8%

Higher than 13% of US stocks

Returns & dividend
Return on equity
25.1%

Higher than 85% of US stocks

Return on assets
−6.8%

Higher than 29% of US stocks

Dividend yield
—

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Peers

AMTX vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelSpecialty Chemicals
CompanyMarket capTKN rank
AMTXAemetis, Inc.$106.3M
29
CITRCitroTech, Inc.$127.6M
14
NTICNorthern Technologies International Corp.$76.2M
40
FSIFlexible Solutions International, Inc.$64.0M
46
CMTCore Molding Technologies, Inc.$216.8M
41
FFFutureFuel Corp.$216.8M
25
MNTKMontauk Renewables, Inc.$243.3M
28
Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. AMTX appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

News

Latest AMTX news & analysis

Alto Ingredients vs. Aemetis: Which Renewable Fuel Stock Wins?

Zacks Investment Research · 28 July 2026neutral

Zacks Investment Research published a comparison of Alto Ingredients (ALTO) and Aemetis (AMTX), noting they are pursuing different renewable fuel strategies while ethanol margins, tax credits, and low-carbon initiatives influence their growth prospects.

Why it matters — The article highlights how external factors like tax credits and low-carbon rules are shaping Aemetis's competitive positioning within the renewable fuel sector.

FAQ

Frequently asked questions about AMTX stock

What is the AMTX stock price forecast for 2026-2027?

The 4 Wall Street analysts covering Aemetis, Inc. have a median 12-month price target of $13, with estimates ranging from $2.5 to $28. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is AMTX stock a buy right now?

Of the 4 analysts covering Aemetis, Inc., 3 rate it a Buy, 1 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Aemetis, Inc. 29 out of 100 across roughly 4,600 US stocks as at 1 Aug 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank AMTX?

As at 1 Aug 2026, Aemetis, Inc. ranks 29 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Growth (81 of 100).

Will AMTX stock go up?

No one can know that. What the data says: the median 12-month target from 4 analysts implies +722.4% from the last close, and Ticker Nerd's factor model ranks Aemetis, Inc. 29 out of 100 as at 1 Aug 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the AMTX stock forecast for 2030?

No analyst covering Aemetis, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for AMTX are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $2.5 to $28 over the next 12 months.

How has AMTX stock performed over the past year?

Aemetis, Inc. returned -43.9% over the 12 months to 3 Aug 2026, with dividends reinvested. Past performance does not indicate future returns.

What does Aemetis, Inc. do?

Aemetis Inc. is a renewable natural gas, renewable fuels, and biochemicals company that develops and commercializes innovative technologies to replace traditional petroleum-based products with low and negative carbon intensity alternatives.

What is the latest news on AMTX?

The most recent item we track (Zacks Investment Research, 28 July 2026): "Alto Ingredients vs. Aemetis: Which Renewable Fuel Stock Wins?". Zacks Investment Research published a comparison of Alto Ingredients (ALTO) and Aemetis (AMTX), noting they are pursuing different renewable fuel strategies while ethanol margins, tax credits, and low-carbon initiatives influence their growth prospects.

Company

About Aemetis, Inc.

Aemetis Inc. is a renewable natural gas, renewable fuels, and biochemicals company that develops and commercializes innovative technologies to replace traditional petroleum-based products with low and negative carbon intensity alternatives. It operates through key segments including California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel, producing ethanol, wet distillers grains, distillers corn oil, condensed distillers solubles for animal feed, distilled biodiesel, refined glycerin, renewable natural gas, USP alcohol, and hand sanitizer. The company owns and manages production facilities such as a large ethanol plant in Keyes, California, a network of biogas digesters converting dairy waste into renewable natural gas, and a biodiesel facility on India's East Coast. Aemetis Inc. also advances sustainable aviation fuel and renewable diesel from agricultural wastes like corn oil, biogas, and wood waste, alongside high-value biochemicals and personal care products through patented industrial biotechnologies and a research laboratory. Founded in 2006 and headquartered in Cupertino, California, Aemetis Inc. plays a significant role in the low-carbon fuels sector by building a circular bioeconomy that utilizes agricultural waste to reduce emissions and enhance air quality.

CEO Mr. Eric A. McAfee · 220 employees · United States · https://www.aemetis.com